Abstract
Biomonitoring has become a standard approach for exposure assessment in occupational and environmental epidemiology. The use of biological effect markers to identify early adverse changes in target organs has also become widely adopted. However, the potential for kidney function to affect biomarker levels in the body and the optimal approach to adjustment of biomarker concentrations in spot urine samples for hydration status are two important but underappreciated challenges associated with biomarker use. Several unexpected findings, such as positive associations between urine nephrotoxicant levels and estimated glomerular filtration rate (eGFR), have been reported recently in research using biomarkers. These and other findings, discussed herein, suggest an impact of kidney glomerular filtration or tubule processing on biomarker levels. This is more commonly raised in the context of decreased kidney filtration, traditionally referred to as reverse causality; however, recent data suggest that populations with normal kidney filtration may be affected as well. Misclassification bias would result if biomarkers reflect kidney function as well as either exposures or early biological effect outcomes. Furthermore, urine biomarker associations with eGFR that differ markedly by approach used to adjust for urine concentration have been reported. Associations between urine measures commonly used for this adjustment, such as urine creatinine, and specific research outcomes could alter observed biomarker associations with outcomes. Research recommendations to address the potential impact of kidney function and hydration status adjustment on biomarkers are provided, including a range of approaches to study design, exposure and outcome assessment, and adjustment for urine concentration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL . Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005; 113: 192–200.
Comper WD, Russo LM . The glomerular filter: an imperfect barrier is required for perfect renal function. Curr Opin Nephrol Hypertens 2009; 18: 336–342.
Bernard A, Thielemans N, Roels H, Lauwerys R . Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995; 52: 177–180.
D'Amico G, Bazzi C . Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003; 12: 639–643.
National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Guideline 1: definition and stages of chronic kidney disease. Am J Kidney Dis 2002; 39: S1.
Evans M, Elinder CG . Chronic renal failure from lead: myth or evidence-based fact? Kidney Int 2011; 79: 272–279.
Marsden PA . Increased body lead burden—cause or consequence of chronic renal insufficiency? N Engl J Med 2003; 348: 345–347.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.
National Kidney Foundation. Glomerular Filtration Rate (GFR) FAQ's. page 4http://www.kidney.org/professionals/kdoqi/gfr.cfm Accessed August 4, 2013.
Nawrot T, Plusquin M, Hogervorst J, Roels HA, Celis H, Thijs L et al. Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 2006; 7: 119–126.
Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC et al. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 2005; 113: 894–899.
Akerstrom M, Barregard L, Lundh T, Sallsten G . The relationship between cadmium in kidney and cadmium in urine and blood in an environmentally exposed population. Toxicol Appl Pharmacol 2013; 268: 286–293.
Nenov VD, Taal MW, Sakharova OV, Brenner BM . Multi-hit nature of chronic renal disease. Curr Opin Nephrol Hypertens 2000; 9: 85–97.
Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992; 41: 1192–1203.
de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 2006; 114: 584–590.
Weaver VM, Lee BK, Ahn KD, Lee GS, Todd AC, Stewart WF et al. Associations of lead biomarkers with renal function in Korean lead workers. Occup Environ Med 2003; 60: 551–562.
Chaumont A, Nickmilder M, Dumont X, Lundh T, Skerfving S, Bernard A . Associations between proteins and heavy metals in urine at low environmental exposures: Evidence of reverse causality. Toxicol Lett 2012; 210: 345–352.
Van Kerkhove E, Pennemans V, Swennen Q . Cadmium and transport of ions and substances across cell membranes and epithelia. Biometals 2010; 23: 823–855.
Weaver VM, Kim NS, Lee BK, Parsons PJ, Spector J, Fadrowski J et al. Differences in urine cadmium associations with kidney outcomes based on serum creatinine and cystatin C. Environ Res 2011; 111: 1236–1242.
Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H . A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 1996; 275: 1177–1181.
Watkins DJ, Josson J, Elston B, Bartell SM, Shin HM, Vieira VM et al. Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect 2013; 121: 625–630.
Sommar JN, Svensson MK, Bjor BM, Elmstahl SI, Hallmans G, Lundh T et al. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ Health 2013; 12: 9.
Boeniger MF, Lowry LK, Rosenberg J . Interpretation of urine results used to assess chemical exposure with emphasis on creatinine adjustments: A review. Am Ind Hyg Assoc J 1993; 54: 615–627.
Suwazono Y, Akesson A, Alfven T, Jarup L, Vahter M . Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers 2005; 10: 117–126.
Aylward LL, Hays SM, Smolders R, Koch HM, Cocker J, Jones K et al. Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev 2014; 17: 45–61.
Abdelmalek JA, Gansevoort RT, Lambers Heerspink HJ, Ix JH, Rifkin DE . Estimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study. Am J Kidney Dis 2014; 63: 415–421.
Yassine H, Kimzey MJ, Galligan MA, Gandolfi AJ, Stump CS, Lau SS . Adjusting for urinary creatinine overestimates arsenic concentrations in diabetics. Cardiorenal Med 2012; 2: 26–32.
Wald R . Urinalysis in the diagnosis of kidney disease. In: Basow D (ed). UpToDate. UpToDate: Waltham, MA. 2013.
Rose B, Post T . Chapter 13B: Meaning of urine osmolality and pH. In: Basow D (ed). UpToDate. UpToDate: Waltham, MA. 2013.
Waikar SS, Sabbisetti VS, Bonventre JV . Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010; 78: 486–494.
Akerstrom M, Lundh T, Barregard L, Sallsten G . Sampling of urinary cadmium: differences between 24-h urine and overnight spot urine sampling, and impact of adjustment for dilution. Int Arch Occup Environ Health 2012; 85: 189–196.
Akerstrom M, Barregard L, Lundh T, Sallsten G . Variability of urinary cadmium excretion in spot urine samples, first morning voids, and 24 h urine in a healthy non-smoking population: implications for study design. J Expo Sci Environ Epidemiol 2014; 24: 171–179.
Moriguchi J, Ezaki T, Tsukahara T, Furuki K, Fukui Y, Okamoto S et al. Comparative evaluation of four urinary tubular dysfunction markers, with special references to the effects of aging and correction for creatinine concentration. Toxicol Lett 2003; 143: 279–290.
Ikeda M, Ezaki T, Tsukahara T, Moriguchi J, Furuki K, Fukui Y et al. Bias induced by the use of creatinine-corrected values in evaluation of beta2-microgloblin levels. Toxicol Lett 2003; 145: 197–207.
Shelley R, Kim NS, Parsons PJ, Lee BK, Agnew J, Jaar BG et al. Uranium associations with kidney outcomes vary by urine concentration adjustment method. J Expo Sci Environ Epidemiol 2014; 24: 58–64.
Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 2005; 113: 1627–1631.
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247–254.
Weaver VM, Vargas GG, Silbergeld EK, Rothenberg SJ, Fadrowski JJ, Rubio-Andrade M et al. Impact of urine concentration adjustment method on associations between urine metals and estimated glomerular filtration rates (eGFR) in adolescents. Environ Res 2014; 132C: 226–232.
Christensen K, Sobus J, Phillips M, Blessinger T, Lorber M, Tan YM . Changes in epidemiologic associations with different exposure metrics: A case study of phthalate exposure associations with body mass index and waist circumference. Environ Int 2014; 73C: 66–76.
Ferraro PM, Costanzi S, Naticchia A, Sturniolo A, Gambaro G . Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health 2010; 10: 304.
You L, Zhu X, Shrubsole MJ, Fan H, Chen J, Dong J et al. Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect 2011; 119: 527–533.
Shelley R, Kim NS, Parsons P, Lee BK, Jaar B, Fadrowski J et al. Associations of multiple metals with kidney outcomes in lead workers. Occup Environ Med 2012; 69: 727–735.
Acknowledgements
The Oak Ridge Institute for Science and Education Research Participation Program at the National Center for Environmental Assessment, Office of Research and Development, US EPA [#: EPA-ORD/NCEA-RTP-2009-02; Dr. Weaver].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Weaver, V., Kotchmar, D., Fadrowski, J. et al. Challenges for environmental epidemiology research: are biomarker concentrations altered by kidney function or urine concentration adjustment?. J Expo Sci Environ Epidemiol 26, 1–8 (2016). https://doi.org/10.1038/jes.2015.8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jes.2015.8
Keywords
This article is cited by
-
Biomonitoring of inorganic arsenic species in pregnancy
Journal of Exposure Science & Environmental Epidemiology (2023)
-
Associations between co-exposure to multiple metals and renal function: a cross-sectional study in Guangxi, China
Environmental Science and Pollution Research (2023)
-
Impact of Dietary Cadmium Intake from Rice on Renal Function Biomarker and Population Toxicokinetic Modelling
Exposure and Health (2023)
-
Variability, Clearance, and Concentration of Multiple Metals and Risk of Kidney Function Abnormality: A New Integrative Metal Exposure Assessment Approach
Exposure and Health (2023)
-
Synergistic impact of co-exposures to whole blood metals on chronic kidney disease in general US adults: a cross‑sectional study of the National Health and Nutrition Examination Survey 2011–2020
Environmental Science and Pollution Research (2023)